Maternal hyperglycemia and metabolic syndromes during pregnancy may influence the expression of cardiogenic transcription factors (e.g., GATA4, NKX2-5), thereby predisposing the fetus to structural cardiac anomalies (7). The gene discussed is NKX2-5; the disease is Hyperglycemia.